Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Elife|December 11, 2020
The leukocyte non-coding RNA landscape in critically ill patients with sepsisBrendon P Scicluna, Fabrice Uhel, Lonneke A van Vught, et al.
Critical Care (London, England)|August 7, 2016
Association of diabetes and diabetes treatment with the host response in critically ill sepsis patientsLonneke A van Vught, Brendon P Scicluna, Arie J Hoogendijk, et al.
Frontiers in Immunology|November 4, 2024
Proteomic profiling of neutrophils and plasma in community-acquired pneumonia reveals crucial proteins in diverse biological pathways linked to clinical outcomeErik H A Michels, Osoul Chouchane, Justin de Brabander, et al.
Journal of Thrombosis and Haemostasis : JTH|December 15, 2025
Plasma proteomics does not identify biomarkers of venous thromboembolism recurrence during and after anticoagulation: results from the VISTA studyEva R Smit, Geke C Poolen, Tirsa T van Duijl, et al.
Frontiers in Immunology|March 15, 2024
SKAP2 acts downstream of CD11b/CD18 and regulates neutrophil effector functionPanagiota Bouti, Bart J A M Klein, Paul J H Verkuijlen, et al.
Critical Care Medicine|March 10, 2016
Admission Hyperglycemia in Critically Ill Sepsis Patients: Association With Outcome and Host ResponseLonneke A van Vught, Maryse A Wiewel, Peter M C Klein Klouwenberg, et al.
Pediatric Research|August 16, 2024
Distinct protein patterns related to postnatal development in small for gestational age preterm infantsEva R Smit, Michelle Romijn, Pieter Langerhorst, et al.
Journal of Innate Immunity|October 26, 2013
Mast cell-deficient kit mice develop house dust mite-induced lung inflammation despite impaired eosinophil recruitmentJ Daan de Boer, Jack Yang, Florry E van den Boogaard, et al.
Critical Care Medicine|February 28, 2017
Sepsis Patients Display a Reduced Capacity to Activate Nuclear Factor-κB in Multiple Cell TypesArie J Hoogendijk, M Isabel Garcia-Laorden, Lonneke A van Vught, et al.
Critical Care (London, England)|November 26, 2015
Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patientsArie J Hoogendijk, Maryse A Wiewel, Lonneke A van Vught, et al.
Pageof 9